Maxsulin R 100iu Vial

What is Maxsulin R?

Maxsulin R is a short-acting (regular) human insulin manufactured by Incepta Pharmaceuticals Ltd., supplied as a clear solution in a vial. It is used to control blood glucose around mealtimes and can be used in combination with longer-acting insulins as part of a complete diabetes management plan.

Generic Name and Composition

Each mL contains 100 IU of Insulin Human (regular, soluble), supplied in a 10 mL vial.

Indications

• Type 1 diabetes mellitus, as part of a basal-bolus insulin regimen
• Type 2 diabetes mellitus when oral antidiabetic agents are insufficient to control blood glucose
• Management of diabetic ketoacidosis and other acute hyperglycemic emergencies (under hospital supervision, often via IV infusion)
• Gestational diabetes, as directed by a physician

How It Works — Mechanism of Action

Regular human insulin is a clear, fast-acting insulin that lowers blood glucose by promoting cellular glucose uptake, particularly in muscle and fat tissue, and by suppressing hepatic glucose production. It has a more rapid onset and shorter duration than NPH or premixed insulins, making it suitable for managing post-meal blood glucose spikes.

Dosage and Administration

• Dosage is strictly individualized by a physician based on blood glucose monitoring, body weight, and meal patterns.
• Administered by subcutaneous injection, usually 15-30 minutes before a meal; may also be given intravenously in hospital settings under medical supervision.
• The solution should appear clear and colorless — do not use if cloudy, discolored, or containing particles.
• Rotate injection sites within the same body region (abdomen, thigh, upper arm) to reduce lipodystrophy.
• Use insulin syringes matched to the vial's concentration (100 IU/mL) to ensure accurate dosing.

Side Effects

Common: Hypoglycemia, injection site reactions (redness, swelling, itching), lipodystrophy with repeated injections at the same site.

Uncommon: Weight gain, peripheral edema (especially when starting therapy).

Rare: Severe allergic reactions (generalized rash, angioedema, anaphylaxis), hypokalemia.

Drug Interactions

May increase hypoglycemia risk: Oral antidiabetic agents, ACE inhibitors, salicylates, alcohol.

May reduce insulin effect / raise blood glucose: Corticosteroids, thiazide diuretics, thyroid hormones, oral contraceptives.

Other considerations: Beta-blockers may mask symptoms of hypoglycemia; inform your doctor of all medicines you are taking.

Contraindications

• Known hypersensitivity to insulin human or any excipient
• Episodes of hypoglycemia requiring caution in dosing adjustment

Pregnancy and Lactation

Human insulin, including regular formulations, is generally considered safe for use during pregnancy and breastfeeding under close physician supervision. Dose requirements often change during pregnancy and require close monitoring.

Precautions and Warnings

• Never share vials or syringes between patients due to infection transmission risk.
• Always verify the insulin type and concentration before each injection.
• Closely monitor blood glucose, especially when changing dose, insulin brand, meal timing, or activity/diet patterns.
• Be aware of signs of hypoglycemia (sweating, palpitations, confusion) and carry a fast-acting sugar source.
• Store correctly — refrigerate unopened vials, keep in-use vials at room temperature, away from direct heat and sunlight.

Overdose

Overdose may cause severe hypoglycemia, with symptoms ranging from sweating and confusion to seizures and loss of consciousness. Mild cases can be managed with oral glucose; severe cases require immediate medical attention, including intravenous glucose or glucagon administration.

Storage Instructions

• Store unopened vials in a refrigerator (2-8°C); do not freeze.
• Once in use, the vial may be kept at room temperature (below 30°C) for up to 4 weeks, away from direct heat and light.
• Keep out of reach of children.
• Do not use after the expiry date printed on the pack.

Frequently Asked Questions

Q1: When should I inject Maxsulin R relative to meals?
It is typically injected 15-30 minutes before a meal to match its onset of action with the rise in blood glucose after eating, as directed by your physician.

Q2: How is Maxsulin R different from Maxsulin N?
Maxsulin R is a fast-acting, clear regular insulin used around mealtimes, while Maxsulin N is an intermediate-acting, cloudy NPH insulin with a delayed, prolonged effect.

Q3: Can Maxsulin R be mixed with Maxsulin N in the same syringe?
Regular and NPH insulins can sometimes be mixed under physician guidance, but proper technique (drawing regular insulin first) is essential — always follow your healthcare provider's specific instructions.

Q4: How does Maxsulin R compare to Maxsulin 30/70?
Maxsulin R contains only fast-acting regular insulin, while Maxsulin 30/70 is a premixed formulation combining 30% regular and 70% NPH insulin for combined mealtime and basal coverage in a single injection.

Medical Disclaimer

This product is available by prescription only (Rx) and should be used under medical supervision. The information provided is for educational purposes and does not replace professional medical advice. Always consult a registered physician before starting, stopping, or changing any insulin therapy. DiabetesStore.com.bd is a licensed online pharmacy in Bangladesh.